Seretide 50 Mcg/250 Mcg Accuhaler Product Imgage
🔒
Secure Payment SSL encrypted
✅
100% Genuine Verified products
🚚
Fast Delivery AU, USA, UK & Canada
↩️
Easy Returns Hassle-free policy
Product Offer

Seretide 50 Mcg/250 Mcg Accuhaler

0 customer reviews
Add Your Review
Free Shipping on Orders above $199! Free
Pack Size Price Quantity Add To Cart
1 Accuhaler AUD $64.01 (64.01 / Unit) Add To Cart
2 Accuhaler AUD $128.03 (64.01 / Unit) Add To Cart
3 Accuhaler AUD $189.00 (63.00 / Unit) Add To Cart
  • 15% OFF 1 Use coupon ARM15
    Click to copy
Active-Ingredient Salmeterol/Fluticasone
Manufacturers
Packaging 60 MDI in 1 Accuhaler
Strength 50Mcg+250Mcg
Delivery-Time 6 To 15 days
Save more with our biggest pack
SKU: ARX988 Categories: ,
in the Last 30 Days
Order Medicines on Call Call us at +1 256 6644170
Active-Ingredient Salmeterol/Fluticasone
Manufacturers
Packaging 60 MDI in 1 Accuhaler
Strength 50Mcg+250Mcg
Delivery-Time 6 To 15 days
Last Updated on ✔ Medically Reviewed by Dr. Arjun Srivastav

Seretide 50 mcg/250 mcg Accuhaler is a prescription dry powder inhaler. It combines two active ingredients in a single device manufactured by GlaxoSmithKline. The medicine is delivered through the Accuhaler, which is designed for oral inhalation.

Australian product references identify this formulation as Seretide Accuhaler 250/50. This notation reflects the standard strength used across local product information.

The two active components are:

This medicine is prescribed for both asthma and chronic obstructive pulmonary disease, also known as COPD. This page covers the product specifications, the role of each ingredient, approved usage for both conditions, the meaning of the strength figures, how the Accuhaler differs from the MDI version, directions for use, dosage guidance, side effects, warnings, and answers to questions people commonly search for.

Seretide 50 mcg/250 mcg Accuhaler Product Information

The table below summarises the key specifications based on current Australian product documentation.

Attribute Information
Brand Seretide
Product variant Accuhaler
Active ingredients Fluticasone propionate and salmeterol (as xinafoate)
Standard strength notation 250 mcg / 50 mcg per dose
Dosage form Powder for inhalation
Device type Dry powder inhaler
Pack size 28 or 60 doses
Prescription status Schedule 4, Prescription Only Medicine
Storage Store below 30°C in a dry place
Sponsor GlaxoSmithKline Australia Pty Ltd

The strength notation 250/50 refers to:

  • 250 micrograms of fluticasone propionate per dose
  • 50 micrograms of salmeterol per dose

The Accuhaler is a two tone purple, circular moulded plastic device with a built in dose counter. Both the 28 dose and the Seretide Accuhaler 60 doses pack configurations are listed in the Australian Register of Therapeutic Goods under ARTG ID 70091. Not all pack sizes may be marketed at any given time.

Active Ingredients in Seretide 50 mcg/250 mcg Accuhaler

The Seretide 50 Mcg/250 Mcg Accuhaler ingredients include two active components. They belong to different classes of respiratory medicine. Each one plays a distinct role, which is why they are combined in a single inhaler for the treatment of both asthma and COPD.

Fluticasone Propionate

Fluticasone propionate is classified as an inhaled corticosteroid. Medicines in this class are described in the product information as working to reduce inflammation in the airways. In prescribed maintenance treatment, the corticosteroid component addresses the inflammatory process in the airway passages over time. This action is relevant for both asthma and COPD patients who require regular anti inflammatory therapy.

Salmeterol

Salmeterol is present in the device as salmeterol xinafoate. It is a long acting beta 2 agonist. This class of medicine is described as relaxing the muscles surrounding the airways, which helps keep the airways open. Salmeterol is referred to as long acting because its duration extends over a longer period compared with short acting reliever medicines. This bronchodilator action supports breathing in both asthma and COPD.

How the Combination Works

The two ingredients have distinct actions and work through different mechanisms:

  • Fluticasone propionate addresses inflammation in the airways
  • Salmeterol relaxes the airway muscles to help keep them open

They are combined in the Accuhaler for the indications specified in the Australian Product Information. The combination is intended for regular maintenance use rather than immediate symptom relief. For both asthma and COPD, the two components work together to address different aspects of the respiratory condition.

What Is Seretide 50 mcg/250 mcg Accuhaler Prescribed For?

Seretide 50 Mcg/250 Mcg Accuhaler is prescribed for two main respiratory conditions. The Australian Product Information outlines its approved role in each.

Use in Asthma

For asthma, Seretide Accuhaler 250/50 is indicated for the regular treatment where a combination product is considered appropriate by a prescriber. This may include:

  • Patients already maintained on separate long acting beta 2 agonist and inhaled corticosteroid therapy
  • Patients who remain symptomatic on current inhaled corticosteroid treatment alone
  • Initiation of maintenance therapy in patients with moderate persistent asthma not adequately controlled on as needed reliever medication

Use in COPD

For chronic obstructive pulmonary disease, the Australian Product Information specifies use in adult patients with severe COPD. These patients must have:

  • A history of repeated exacerbations
  • Significant symptoms despite regular bronchodilator therapy

Seretide is not indicated for the initiation of bronchodilator therapy in COPD.

Maintenance Treatment, Not Relief

An important distinction is that this medicine is a maintenance treatment for both asthma and COPD. It is not designed to provide immediate relief from sudden breathing symptoms. Whether this formulation is suitable depends on the individual patient, the severity of their condition, and the clinical assessment of the prescriber.

Understanding the differences between asthma and COPD can help explain why diagnosis and treatment depend on the underlying respiratory condition.

Understanding the Seretide 50 mcg/250 mcg Accuhaler Strength

The two numbers in Seretide 50 Mcg/250 Mcg Accuhaler represent the amount of each active ingredient per dose:

  • 250 mcg is the amount of fluticasone propionate
  • 50 mcg is the amount of salmeterol, present as salmeterol xinafoate

These figures represent the pre dispensed dose, which is the amount contained in each blister before inhalation. The delivered dose, meaning the amount leaving the mouthpiece, is slightly lower at approximately 231 mcg of fluticasone propionate and 47 mcg of salmeterol. This distinction is documented in the official product information.

The 250/50 strength differs from other available Accuhaler strengths:

  • 100/50 (lower fluticasone amount)
  • 250/50 (this formulation)
  • 500/50 (higher fluticasone amount)

The fluticasone component changes between strengths while the salmeterol amount remains 50 mcg across all three. Different strengths are not interchangeable without professional advice, as the prescriber selects the strength based on the severity of the condition, whether it is asthma or COPD.

Seretide 50 mcg/250 mcg Accuhaler Versus Seretide MDI

Seretide is available in two device types. The table below outlines the main differences.

Feature Accuhaler MDI
Device type Dry powder inhaler Pressurised metered dose inhaler
Delivery format Powder inhaled through the device Metered aerosol released from the device
Technique Device specific inhalation technique Different inhalation technique
Available strengths 100/50, 250/50, 500/50 50/25, 125/25, 250/25

Key differences to note:

  • The Accuhaler delivers powder from a pre measured blister
  • The MDI releases a metered aerosol spray
  • Each device requires a different inhalation technique
  • The MDI strengths use a 25 mcg salmeterol component compared with 50 mcg in the Accuhaler

Both device types are used for asthma and COPD, but they should not be treated as interchangeable. The instructions for one should not be applied to the other. Different types of asthma inhalers have different delivery mechanisms and operating instructions.

How to Use Seretide 50 mcg/250 mcg Accuhaler

The following is a brief overview based on the manufacturer instructions. The full directions are provided in the leaflet supplied with the device, and those should be the primary reference for patients using the inhaler for asthma or COPD.

Preparing the Inhaler

The Accuhaler is opened by holding the outer case and pulling the mouthpiece open until it clicks. The dose is prepared by sliding the lever until it stops. This loads a single blister of powder for inhalation.

Inhaling the Dose

After the dose is loaded, the patient exhales fully away from the mouthpiece. They then seal their lips around the mouthpiece and breathe in steadily and deeply through the mouth. The correct technique is device specific and patients should confirm their approach with their doctor or pharmacist.

Care After Inhalation

The Consumer Medicine Information advises rinsing the mouth with water and spitting it out after using the inhaler. This practice is recommended to help reduce the risk of oral thrush, which is a commonly reported side effect of inhaled corticosteroids used in both asthma and COPD treatment.

Checking the Dose Counter

The Accuhaler has a dose counter that indicates the number of doses remaining.

  • When the counter reads zero, the device is empty and should be replaced
  • Patients should check the counter regularly to avoid running out of medicine unexpectedly

💡 Tip

Breathe out away from the device before inhaling the dose, and follow the Accuhaler instructions provided by your pharmacist.

Seretide 50 mcg/250 mcg Accuhaler Dosage and Regular Use

Patients should use Seretide 50 Mcg/250 Mcg Accuhaler exactly as directed by their doctor or pharmacist. The usual dose for adults and adolescents 12 years and older is one inhalation twice daily. The prescriber selects the strength based on the severity of the condition, whether it is asthma or COPD.

Important points about dosage:

  • Do not change the dose without professional advice
  • Do not stop treatment without consulting a doctor
  • Use the medicine regularly every day, even when feeling well

If a dose is missed, the official instructions advise taking it as soon as remembered, unless it is nearly time for the next scheduled dose. In that case, the missed dose should be skipped and the regular schedule resumed. A double dose should not be used to make up for a missed one.

Patients who notice their breathing or wheezing worsening, or who need their reliever inhaler more often than usual, should seek medical review. Increased breathing difficulties in either asthma or COPD may indicate that the current treatment plan needs reassessment.

🔵 Reminder

Use Seretide regularly as prescribed. Do not change the dose or stop treatment without consulting your healthcare professional.

Seretide 50 mcg/250 mcg Accuhaler Side Effects

Side effects are organised below by the type of response they may require. Information is drawn from the current Consumer Medicine Information. These effects apply to patients using the inhaler for either asthma or COPD.

Common Side Effects
Serious Side Effects
Common Side Effects
🗣️ Hoarseness
👄 Soreness of the mouth, throat or tongue
❤️ Increased heart rate
🤕 Headache
💪 Muscle cramps
🦴 Pains in the joints
Serious Side Effects
😳 Wheezing or difficulty breathing
🧊 Swelling of the face, lips, mouth, tongue or throat
💢 Chest pain or tightness
😵 Fainting
😶‍🌫️ Shortness of breath
💓 Irregular heartbeat
🗣️ Hoarseness
😳 Wheezing or difficulty breathing
👄 Soreness of the mouth, throat or tongue
🧊 Swelling of the face, lips, mouth, tongue or throat
❤️ Increased heart rate
💢 Chest pain or tightness
🤕 Headache
😵 Fainting
💪 Muscle cramps
😶‍🌫️ Shortness of breath
🦴 Pains in the joints
💓 Irregular heartbeat

Reducing the Risk of Side Effects

Patients can take the following steps to help reduce certain side effects:

  • Use the correct device technique to minimise medicine deposited in the mouth
  • Rinse the mouth with water after each use and spit it out to help reduce the risk of oral thrush
  • Report any persistent or troublesome effects to a doctor or pharmacist

❗ Important

Rinse your mouth with water and spit it out after each dose to help reduce the risk of oral thrush.

Warnings, Precautions and Medicine Interactions for Seretide 50 mcg/250 mcg Accuhaler

Several precautions are documented in the Australian product information for Seretide Accuhaler. These apply to patients being treated for both asthma and COPD.

The Accuhaler should not be used by anyone with a known allergy to:

  • Fluticasone propionate
  • Salmeterol xinafoate
  • Any of the listed ingredients

Because the Accuhaler contains lactose monohydrate as an excipient, and lactose in this formulation contains milk proteins, the device is contraindicated in patients with severe milk protein allergy.

Patients should inform their prescriber about other medical conditions, including:

  • Tuberculosis
  • Diabetes
  • Thyroid conditions
  • High blood pressure
  • Heart problems
  • Low blood potassium levels

People taking other steroid medicines, by mouth or inhalation, should also discuss this with their doctor.

Regarding medicine interactions, the product information notes:

  • Beta blockers should generally be avoided
  • Ritonavir can significantly increase fluticasone propionate plasma concentrations and should be avoided unless the benefit outweighs the risk
  • Ketoconazole can increase exposure to salmeterol, and care is advised when co administering potent cytochrome P450 3A4 inhibitors

For pregnancy and breastfeeding, the medicine is classified as Pregnancy Category B3. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and benefits with their doctor before use.

⚠️ Warning

Seretide is not a rescue inhaler for sudden breathing problems. Follow your asthma action plan and seek urgent help if symptoms are severe or worsening.

Can Seretide 50 mcg/250 mcg Accuhaler Be Used for a Sudden Asthma Attack?

No. Seretide 50 Mcg/250 Mcg Accuhaler is a maintenance treatment for both asthma and COPD. It is not intended to provide immediate relief during a sudden asthma attack or a COPD flare-up. Repeated nighttime asthma symptoms should be discussed with a healthcare professional, particularly when they interrupt sleep.

Patients should:

  • Follow their written asthma or COPD action plan
  • Use their prescribed reliever inhaler for acute symptoms

For severe breathing difficulty in Australia, call Triple Zero (000).

How to Store Seretide 50 mcg/250 mcg Accuhaler

The product instructions specify:

  • Store below 30°C in a dry place
  • Keep away from direct heat and sunlight
  • Keep the device closed when not in use
  • Check the expiry date on the packaging
  • Monitor the dose counter to track remaining doses

When the device is empty or past its expiry date, it should be disposed of according to the recommendations of a pharmacist.

FAQs

What Are the Ingredients in Seretide 50 mcg/250 mcg Accuhaler?

The active ingredients are fluticasone propionate at 250 mcg per pre dispensed dose and salmeterol, as salmeterol xinafoate, at 50 mcg per pre dispensed dose. The Accuhaler also contains the excipient lactose monohydrate, which includes milk proteins.

Is Seretide Accuhaler the Same as Seretide MDI?

They are not the same. The Accuhaler is a dry powder inhaler that delivers powder from a pre measured blister, while the MDI is a pressurised metered dose inhaler that releases an aerosol spray. The two devices use different inhalation techniques and have different available strengths.

Is Seretide Accuhaler a Reliever Inhaler?

Seretide Accuhaler is a maintenance treatment used regularly as prescribed for both asthma and COPD. It is not a reliever and should not be relied on for sudden breathing symptoms. Patients should use their prescribed reliever inhaler according to their asthma or COPD action plan for acute episodes.

How Many Doses Are in Seretide 50 mcg/250 mcg Accuhaler?

The Accuhaler is available in two pack sizes, 28 doses per device and 60 doses per device. The Seretide Accuhaler 60 doses pack is the more commonly dispensed configuration. The device has a built in dose counter that tracks remaining doses. When the counter reads zero, the device is empty and should be replaced.

Can I Use Seretide Accuhaler During Pregnancy?

The medicine is classified as Pregnancy Category B3. Patients who are pregnant, planning pregnancy, or breastfeeding should discuss the risks and benefits with their doctor before use. The doctor can assess whether continued treatment is appropriate based on the individual situation.

What Should I Do If I Miss a Dose of Seretide Accuhaler?

If a dose is missed, take it as soon as remembered, unless it is nearly time for the next scheduled dose. In that case, skip the missed dose and resume the regular schedule. Do not use a double dose to make up for a missed one. If you are unsure what to do, ask your doctor or pharmacist for guidance.

0.0
★ ★ ★ ★ ★
(0 Reviews)
5 star
0%
4 star
0%
3 star
0%
2 star
0%
1 star
0%
0%
would recommend
to a friend.
Write a review

No reviews yet.

Be the first to review “Seretide 50 Mcg/250 Mcg Accuhaler”

Your email address will not be published. Required fields are marked *

About the Doctor

Dr. Arjun Srivastav

Medical Reviewer (Pharm D)

✔ Medically Reviewed • Updated: 10/23/2026

Education: Graduate Diploma in Clinical Practice - University of Sydney,

Clinical Pharmacist (Pharm D) Doctor of Medicine (MD) – University of Melbourne Biomedical Engineering – Monash University Graduate Diploma in Clinical Practice - University of Sydney, Arjun Srivastav is a dedicated Clinical Pharmacologist and the E-commerce Operations Manager at AustraliaRxMeds. With a Doctor of Pharmacy (Pharm D) and over 10 years of clinical experience at prestigious institutions like Wockhardt and Apollo Hospitals, Arjun specializes in drug safety, digital healthcare accessibility,...

Read more